全文获取类型
收费全文 | 10327篇 |
免费 | 1094篇 |
国内免费 | 559篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 53篇 |
妇产科学 | 315篇 |
基础医学 | 1901篇 |
口腔科学 | 35篇 |
临床医学 | 673篇 |
内科学 | 1968篇 |
皮肤病学 | 72篇 |
神经病学 | 30篇 |
特种医学 | 290篇 |
外国民族医学 | 19篇 |
外科学 | 1320篇 |
综合类 | 1263篇 |
现状与发展 | 2篇 |
预防医学 | 162篇 |
眼科学 | 40篇 |
药学 | 412篇 |
3篇 | |
中国医学 | 85篇 |
肿瘤学 | 3301篇 |
出版年
2024年 | 49篇 |
2023年 | 257篇 |
2022年 | 589篇 |
2021年 | 689篇 |
2020年 | 499篇 |
2019年 | 467篇 |
2018年 | 372篇 |
2017年 | 425篇 |
2016年 | 549篇 |
2015年 | 539篇 |
2014年 | 791篇 |
2013年 | 619篇 |
2012年 | 524篇 |
2011年 | 517篇 |
2010年 | 421篇 |
2009年 | 405篇 |
2008年 | 424篇 |
2007年 | 469篇 |
2006年 | 433篇 |
2005年 | 396篇 |
2004年 | 301篇 |
2003年 | 281篇 |
2002年 | 255篇 |
2001年 | 187篇 |
2000年 | 169篇 |
1999年 | 138篇 |
1998年 | 157篇 |
1997年 | 153篇 |
1996年 | 120篇 |
1995年 | 111篇 |
1994年 | 104篇 |
1993年 | 77篇 |
1992年 | 59篇 |
1991年 | 68篇 |
1990年 | 47篇 |
1989年 | 47篇 |
1988年 | 45篇 |
1987年 | 35篇 |
1986年 | 29篇 |
1985年 | 27篇 |
1984年 | 19篇 |
1983年 | 28篇 |
1982年 | 14篇 |
1981年 | 20篇 |
1980年 | 23篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1976年 | 4篇 |
1973年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
The incidence of the adenocarcinoma of the esophagus (AC) has been rising exponentiallyin the Western World within the last 30 years.The reasons for this increase are not yet understood.Massive and long lasting gastroesophageal reflux causes the Barrett's esophagus which is considered tobe a precaneerosis.Therefore early diagnosis and appropriate treatment of gastroesophageal reflux isessential for the prevention of this tumor.This makes heartburn the leading clinical symptom in thepatient's history.In patients with heartburn it is possible to early endoscopically diagnose a Barrett'sesophagus or adenocarcinoma of the esophagus.However only few patients with this increased risk receivean index-endoscopy.In clinical studies a high rate of early carcinomas could be found and could be treatedwith mueosectomie or ablation.The majority of patients with AC present with symptoms suggestive ofprogressed disease such as dysphagia or weight loss.The prognosis in patients in late disease stages are witha 5-year survival of only 30% far worse than in patients with early carcinoma (85%).However the earlysymptoms such as heartburn or regurgitation are unspecific and make an effective diagnostical strategydifficult.To optimize screening it would be beneficial to identify patients with high risk for the developmentof adenocarcinoina of the esophagus. 相似文献
72.
Incidence of esophageal carcinoma With more than 300 000 new cases per year, cancerof the esophagus, predominantly squamous cell carcinoma(SCC), is one of the 10 most frequently diagnosed tumortypes. Esophageal cancer occurs often in developing coun-tries and shows great regional di?erences[1]. While in re-cent history the incidence of SCC has decreased slightly inregions of high risk and stayed constant in the USA andWestern Europe, the rate of adenocarcinoma of the esoph-agus (AC) has… 相似文献
73.
38例肺源性脑转移瘤临床病理分析 总被引:1,自引:0,他引:1
目的 肺源性脑转移瘤临床病理特征。方法 研究38例肺源性脑转移瘤的临床和病理特点,男性27例,女性11例;年龄在30-74岁之间。其中5例转移性癌作免疫组织化学染色和电镜观察。结果 20例为腺癌,12/20为乳头状腺癌;5例为腺鳞癌,7例为鳞形细胞癌,4例为燕麦细胞癌,2例为不典型类癌;5例乳头状腺癌作免疫组织化学染色示CK(5/5)和CEA(4/5)为阳性;电镜显示转移性乳头状腺癌具有肺泡Ⅱ型上皮细胞分化潜能。结论 肺癌中腺癌更易发生脑转移,免疫组织化学在鉴别诊断中有一定的辅助作用,转移性乳头状腺癌具有异质性。 相似文献
74.
75.
Both the antigen presenting ability and the cytotoxicity of macrophages can be enhanced by GM-CSF gene transfer. In the present
study, the therapeutic effect of intratumoral injection with GM-CSF gene-modified allogenic macrophages on tumor-bearing mice
observed. The peritoneal macrophages of C57BL/6 mice were transfected with GM-CSF gene mediated by recombinant adenovirus
and the subcutaneous CT26 colon adeno-carcinoma-bearing BALB/c mice were treated by intratumoral injection of the above macrophages.
The survival time of the tumor-bearing mice were prolonged significantly and some tumor mass disappeared completely. The necroses
of the tumor cells and massive infiltration of inflammatory cells were observed 6 days after treatment 30 days after treatment,
only the leftover of tumor cells and the inflammatory cells remained. The data indicated that introtumoral injection of GM-CSF
gene-modified allogenic macrophages displayed more potent therapeutic effect on the preestablished tumor-bearing mice.
Supported by National High Biotechnology Foundation (Z20-01-03).
This is one of papers of the special issue on gene therapy research (Chin J Cancer Res Vol. 9 No. 4 December, 1997). 相似文献
76.
Cutaneous manifestations of malignancy are not uncommon, especially in advanced disease. They may also occur early in malignant disease or they may even signify recurrence particularly if they are paraneoplastic in nature. Clinical diagnosis can be difficult because of the wide spectrum of appearance of these lesions, and, in many cases, because of the lack of an identifiable underlying primary. Presented here is the case of a 65-year-old woman with multiple inflammatory cutaneous metastases, which were sclerodermoid in nature. These appeared 14 months after initial diagnosis of adenocarcinoma of unknown primary (ACUP) and signified the beginning of a rapid deterioration in her condition. The coexistence of limited systemic sclerosis (scleroderma) and ACUP initially raised several interesting diagnostic possibilities. Adenocarcinoma of unknown primary and the sclerodermoid reaction in malignancy are discussed. 相似文献
77.
H. Nagano K. Mizutani K. Sawa Y. Ozaki A. Murakami 《International journal of clinical oncology / Japan Society of Clinical Oncology》1998,3(5):330-333
We report a case of stage IV ovarian clear cell adenocarcinoma (OCCA) in a 72-year-old woman who was treated postoperatively
with etoposide combined with cisplatin (EP). The patient exhibited bulky intrapelvic and para-aortic lymph nodes with metastases
to the cervical lymph nodes. The primary lesion was resected and, postoperatively, she received one course of combination
chemotherapy consisting of cyclophosphamide, 500 mg/m2; doxorubicin, 50 mg/m2; and cisplatin, 70mg/m2 (CAP), followed by six courses of combination chemotherapy consisting of etoposide, 80mg/m2 days 1 through 5 and cisplatin, 70 mg/m2 on day 5 every 4 weeks. After five courses of EP, the lymph node metastases had virtually disappeared. The patient is now
disease-free 21 months after the initial surgery. These findings suggest that EP may be useful in treating OCCA. 相似文献
78.
目的建立N一甲基一N’一硝基一N一亚硝基胍(N-methy1-N’-nitro-N-nitrosoguanidine,MNNG)诱发大鼠腺胃癌模型并观察p53,ras基因的表达。方法给Wistar大鼠饮用MNNG水溶液(终浓度为80μg/ml),用ABC法检测P53和P21蛋白的表达。结果MNNG成功地诱发出了胃癌、胃腺瘤、胃息肉、胃粘膜不典型增生和历上皮化生等病变。胃癌肝转移2例,淋巴结转移1例。P53蛋白在肠化及不典型增生皆阴性,胃癌阳性率为50%;P21蛋白在肠化及不典型增生中阳性率为44%,在癌组织中为23%。结论MNNG能诱发大鼠脾胃癌等病变,P53基因突变在胃癌发生发展过程中起一定作用,而ras基因激活是一个早期现象。 相似文献
79.
通过体内实验进一步证实rhPRL对机体免疫功能的调节作用,以及用于过继细胞免疫治疗的可能性。我们选用CB17 SCID纯系小鼠,腹腔注入人结肠腺癌细胞(HT29),2小时后腹腔注入尼龙毛纯化的人淋巴细胞(T/NK细胞),同时开始进行rhPRL治疗,并设HBSS对照和rhIL-2治疗对照组。结果表明,rhPRL在体内外均无直接抗癌效应,反而可促进肿瘤生长。当SCID荷瘤鼠同时移植入人的T/NK细胞时出rhPRL可明显提高T/NK细胞的抗癌效果,生存期明显延长(P<0.05)。平均生存期由70.4天延至112.1天,在对照组全部死亡时(d105),rhPRL治疗组有60%存活,且在实验终止时(>160天)仍有40%存活。分析其抗癌机理发现,rhPRL体外可直接促进人T/NK细胞增殖,其分泌上清可抑制肿瘤生长,同时发现人T/NK细胞与HT29共育4小时中rhPRL亦可直接促进杀伤活性。 相似文献
80.
本室以往的研究表明,用腺病毒作为载体将大肠杆菌胞嘧啶脱氨酶(CD)基因与小鼠淋巴细胞趋化因子(Itn)基因联合体内转染,具有显著的抗肿瘤效应.本文对其免疫机理进行了进一步研究,发现CT26结肠腺癌细胞体外经过CD/Ltn基因转染并给予前体药物5-FC后,CT26结肠腺癌细胞表达CD80和CD54分子明显增加,提示经CD自杀基因和Ltn基因联转移后,肿瘤细胞免疫原性增加.荷瘤小鼠体内经联合治疗后,小鼠脾细胞分泌IL-2和IFN-γ明显增加.体内用抗CD4、CD8抗体阻断实验研究结果的表明,联合应用自杀基因和Ltn基因治疗主要通过诱导CD8~ T细胞发挥抗肿瘤作用. 相似文献